Literature DB >> 7580929

Nonradioactive multiplex PCR screening strategy for the simultaneous detection of multiple low-density lipoprotein receptor gene mutations.

M J Kotze1, L Theart, M Callis, A V Peeters, R Thiart, E Langenhoven.   

Abstract

We have developed a rapid, nonradioactive screening test enabling the simultaneous analysis of three low-density lipoprotein receptor (LDLR) gene mutations (D154N, D206E, and V408M), which together account for familial hypercholesterolemia (FH) in approximately 90% of the South African Afrikaner population. The assay is designed so that FH patients, negative for these founder-related mutations (found in descendants of European settlers), subsequently can be screened for unknown mutations in the mutation-rich exon 4 of the LDLR gene. Our screening assay consists of two steps: (1) multiplex allele-specific PCR amplification of exons 4 and 9, and (2) simultaneous analysis of single- and double-strand conformational polymorphisms in exon 4 by vertical electrophoresis on low cross-linked polyacrylamide gels. The simplicity, specificity, and versatility of the multiplex assay makes it an ideal system for routine screening of FH mutations in large population samples.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7580929     DOI: 10.1101/gr.4.6.352

Source DB:  PubMed          Journal:  PCR Methods Appl        ISSN: 1054-9803


  7 in total

1.  The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population.

Authors:  Monique G Zaahl; Trevor A Winter; Louise Warnich; Maritha J Kotze
Journal:  Int J Colorectal Dis       Date:  2005-07-30       Impact factor: 2.571

2.  Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.

Authors:  R Thiart; C L Scholtz; J Vergotine; C F Hoogendijk; J N de Villiers; H Nissen; K Brusgaard; D Gaffney; M S Hoffs; W J Vermaak; M J Kotze
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

3.  Genetic analysis of Indian subjects with clinical features of possible type IIa hypercholesterolemia.

Authors:  Altaf A Kondkar; Kappiareth G Nair; Tester F Ashavaid
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

4.  Molecular basis of familial hypercholesterolemia: An Indian experience.

Authors:  T F Ashavaid; A K Altaf; K G Nair
Journal:  Indian J Clin Biochem       Date:  2000-08

5.  Simultaneous detection of multiple familial hypercholesterolemia mutations facilitates an improved diagnostic service in South african patients at high risk of cardiovascular disease.

Authors:  Maritha J Kotze; Gernot Kriegshäuser; Rochelle Thiart; Nico J P de Villiers; Charlotte L Scholtz; Fritz Kury; Anne Moritz; Christian Oberkanins
Journal:  Mol Diagn       Date:  2003

6.  A novel deletion at codon 441 of the APC gene associated with ophthalmic lesions (CHRPE) in a South African family.

Authors:  J J Grobbelaar; A Ziskind; G de Jong; C J Oosthuizen; M J Kotze
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

7.  Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy.

Authors:  Frederick Raal; Vanessa Panz; Andrew Immelman; Gillian Pilcher
Journal:  J Am Heart Assoc       Date:  2013-04-24       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.